AVXL Valuation
Anavex Life Sciences Corp
$
9.360
- Overview
- Forecast
- Valuation
AVXL Relative Valuation
AVXL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVXL is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
7.13
P/B
Median3y
4.78
Median5y
7.15
-4.41
FCF Yield
Median3y
-4.86
Median5y
-4.61
Competitors Valuation Multiple
The average P/S ratio for AVXL's competitors is 15.76, providing a benchmark for relative valuation. Anavex Life Sciences Corp Corp (AVXL) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
RWAY
Runway Growth Finance Corp
9.210
USD
+1.43%
CYD
China Yuchai International Ltd
16.610
USD
+8.56%
ACTG
Acacia Research Corp
3.160
USD
+0.32%
ZVRA
Zevra Therapeutics Inc
8.000
USD
+4.71%
CWCO
Consolidated Water Co Ltd
23.170
USD
+0.13%
SHYF
Shyft Group Inc
9.160
USD
+4.81%
TCMD
Tactile Systems Technology Inc
14.080
USD
+1.81%
JILL
JJill Inc
15.860
USD
+2.12%
METC
Ramaco Resources Inc
10.000
USD
+0.50%
TBPH
Theravance Biopharma Inc
10.370
USD
-0.19%
FAQ
Is Anavex Life Sciences Corp (AVXL) currently overvalued or undervalued?
Anavex Life Sciences Corp (AVXL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 145.15. The fair price of Anavex Life Sciences Corp (AVXL) is between to according to relative valuation methord.
What is Anavex Life Sciences Corp (AVXL) fair value?
How does AVXL's valuation metrics compare to the industry average?
What is the current P/B ratio for Anavex Life Sciences Corp (AVXL) as of May 03 2025?
What is the current FCF Yield for Anavex Life Sciences Corp (AVXL) as of May 03 2025?
What is the current Forward P/E ratio for Anavex Life Sciences Corp (AVXL) as of May 03 2025?